AGILE THERAPEUTICS INC Contracts & Agreements

Amendment No. 3 to Manufacturing and Commercialization Agreement, by and between Corium, Inc. and Agile Therapeutics, Inc., dated as of June 25, 2024 (Filed With SEC on July 16, 2024)

Amendment No. 2 to Manufacturing and Commercialization Agreement, by and between Corium, Inc. and Agile Therapeutics, Inc., dated as of May 15, 2024 (Filed With SEC on July 15, 2024)

Agreement and Plan of Merger, dated June 25, 2024, by and among Insud Pharma, S.L., Exeltis Project, Inc. and the Company (Filed With SEC on June 26, 2024)

Cash-Out Acknowledgement and Cancellation Agreement, dated June 25, 2024, by and between Armistice Master Fund Ltd. and the Company (Filed With SEC on June 26, 2024)

Revolving Promissory Note dated June 25, 2024, by and between the Company and Exeltis USA, Inc (Filed With SEC on June 26, 2024)

Intellectual Property Security Agreement dated June 25, 2024 by and between the Company and Exeltis USA, Inc (Filed With SEC on June 26, 2024)

Amendment No. 2 to Manufacturing and Commercialization Agreement, by and between Corium, Inc. and Agile Therapeutics, Inc., dated as of May 15, 2024 (Filed With SEC on June 14, 2024)

Form of New Warrant (Filed With SEC on February 23, 2024)

Form of Placement Agent Warrant (Filed With SEC on February 23, 2024)

Form of Exercise Agreement (Filed With SEC on February 23, 2024)

Eighth Amendment to Credit Agreement and Guaranty, by and among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on February 15, 2024)

Form of Series E-1 Warrant (Filed With SEC on December 20, 2023)

Form of Series E-2 Warrant (Filed With SEC on December 20, 2023)

Form of Series F Pre-Funded Warrant (Filed With SEC on December 20, 2023)

Form of Placement Agent Warrant (Filed With SEC on December 20, 2023)

Form of Securities Purchase Agreement, by and among Agile Therapeutics, Inc. and the purchasers signatory thereto (Filed With SEC on December 20, 2023)

Amendment to Warrants and Certificate of Adjustment between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of October 30, 2023 (Filed With SEC on December 11, 2023)

Seventh Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and... (Filed With SEC on December 11, 2023)

Form of New Warrant (Filed With SEC on December 4, 2023)

Form of Warrant Amendment and Additional Issuance Agreement (Filed With SEC on December 4, 2023)

Transition and Separation Agreement, dated August 17, 2023, by and between Agile Therapeutics, Inc. and Jason Butch (Filed With SEC on November 9, 2023)

Seventh Amendment to Project Agreement, dated September 28, 2023, by and between Agile Therapeutics, Inc., and Syneos Health Commercial Services, LLC (Filed With SEC on September 28, 2023)

Employment Agreement, dated August 16, 2023, by and between Agile Therapeutics, Inc. and Scott Coiante (Filed With SEC on August 22, 2023)

Form of Series C-1 warrant (Filed With SEC on May 25, 2023)

Form of Series C-2 warrant (Filed With SEC on May 25, 2023)

Form of Series D Pre-funded warrant (Filed With SEC on May 25, 2023)

Form of Placement Agent warrant (Filed With SEC on May 25, 2023)

Form of Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated October 8, 2021 (Filed With SEC on May 25, 2023)

Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated March 14, 2022 (Filed With SEC on May 25, 2023)

Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated April 25, 2022 (Filed With SEC on May 25, 2023)

Form of Amended and Restated Series A-1 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated July 6, 2022 (Filed With SEC on May 25, 2023)

Form of Amended and Restated Series A-2 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated July 6, 2022 (Filed With SEC on May 25, 2023)

Form of Amended and Restated Series B Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated March 14, 2022 (Filed With SEC on May 25, 2023)

Form of Securities Purchase Agreement, dated May 22, 2023, by and between Agile Therapeutics, Inc. and certain purchasers (Filed With SEC on May 25, 2023)

Form of Warrant Amendment Agreement, dated May 22, 2023, by and between Agile Therapeutics, Inc. and certain holders (Filed With SEC on May 25, 2023)

Form of Series C-1 Warrant (Filed With SEC on May 19, 2023)

Form of Series C-2 Warrant (Filed With SEC on May 19, 2023)

Form of Series D Pre-Funded Warrant (Filed With SEC on May 19, 2023)

Form of Placement Agent Warrant (Filed With SEC on May 19, 2023)

Form of Securities Purchase Agreement, by and between Agile Therapeutics, Inc. and the purchasers signatory thereto (Filed With SEC on May 19, 2023)

Waiver and Sixth Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on April 14, 2023)

Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of March 21, 2023 (Filed With SEC on March 23, 2023)

Sixth Amendment to Project Agreement, dated January 3, 2023, by and between Agile Therapeutics, Inc. and inVentiv Commercial Services, LLC (Filed With SEC on March 23, 2023)

Amended and Restated Employment Agreement, dated November 22, 2022 by and between Agile Therapeutics, Inc. and Alfred Altomari (Filed With SEC on March 23, 2023)

Amended and Restated Employment Agreement, dated November 1, 2022 by and between Agile Therapeutics, Inc. and Geoffrey P. Gilmore (Filed With SEC on March 23, 2023)

Amended and Restated Employment Agreement, dated November 1, 2022 by and between Agile Therapeutics, Inc. and Paul Korner, MD (Filed With SEC on March 23, 2023)

Fifth Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and... (Filed With SEC on November 7, 2022)

Amendment No. 1 to Manufacturing and Commercialization Agreement, by and between Corium, Inc. and Agile Therapeutics, Inc., dated as of July 25, 2022, and Bill of Sale by Agile... (Filed With SEC on November 7, 2022)

Form of Series A-1 warrant (Filed With SEC on July 8, 2022)

Form of Series A-2 warrant (Filed With SEC on July 8, 2022)

Form of Series B Pre-funded warrant (Filed With SEC on July 8, 2022)

Form of Placement Agent warrant (Filed With SEC on July 8, 2022)

Form of Securities Purchase Agreement, dated July 1, 2022, by and between Agile Therapeutics, Inc. and certain purchasers (Filed With SEC on July 8, 2022)

Form of Series A-1 Warrant (Filed With SEC on June 29, 2022)

Form of Series A-2 Warrant (Filed With SEC on June 29, 2022)

Form of Series B Pre-Funded Warrant (Filed With SEC on June 29, 2022)

Form of Placement Agent Warrant (Filed With SEC on June 29, 2022)

Form of Securities Purchase Agreement, by and between Agile Therapeutics, Inc. and the purchasers signatory thereto (Filed With SEC on June 29, 2022)

Engagement Agreement, by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 29, 2022)

Amendment to Engagement Agreement, by and between Agile Therapeutics, Inc. and H.C. Wainright & Co., LLC (Filed With SEC on June 29, 2022)

FifthAmendment to Master Service Agreement, dated February 1, 2022, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on May 12, 2022)

Waiver and Fourth Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on May 12, 2022)

Common Stock Sales Agreement dated April 27, 2022 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 27, 2022)

Fourth Amendment to Master Service Agreement, dated September 1, 2021, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on March 30, 2022)

Form of Series A Warrant (Filed With SEC on March 15, 2022)

Form of Series B Warrant (Filed With SEC on March 15, 2022)

Form of Placement Agent Warrant (Filed With SEC on March 15, 2022)

Form of Securities Purchase Agreement, dated March 13, 2022, by and between Agile Therapeutics, Inc. and the purchaser signatory thereto (Filed With SEC on March 15, 2022)

Waiver and Third Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on March 11, 2022)

Controlled Equity OfferingSM Sales Agreement dated January 10, 2022 by and among Agile Therapeutics, Inc. and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (Filed With SEC on January 10, 2022)

Waiver and Second Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on January 10, 2022)

Lease agreement, dated August 6, 2021 by and between the Registrant and 500 College Road Venture, LLC (Filed With SEC on November 2, 2021)

Second Amendment to Master Service Agreement, dated January 1, 2021, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on November 2, 2021)

Third Amendment to Master Service Agreement, dated July 1, 2021, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on November 2, 2021)

Underwriting Agreement dated October 8, 2021 (Filed With SEC on October 8, 2021)

Form of Warrant (Filed With SEC on October 8, 2021)

Common Stock Sales Agreement dated March 18, 2021 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 18, 2021)

Warrant Agreement between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of February 26, 2021 (Filed With SEC on March 1, 2021)

Waiver and First Amendment to Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party... (Filed With SEC on March 1, 2021)

First Amendment to Project Agreement, dated June 1, 2020, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on March 1, 2021)

Sixth Lease Amendment, dated November 11, 2020, by and between the Registrant and Bunn Farm Associates, LLC (Filed With SEC on November 12, 2020)

Amended and Restated Employment Agreement, dated August 14, 2020, by and between the Registrant and Alfred Altomari (Filed With SEC on August 17, 2020)

Amended and Restated Employment Agreement, dated August 14, 2020, by and between the Registrant and Robert Conway (Filed With SEC on August 17, 2020)

Amended and Restated Employment Agreement, dated August 14, 2020, by and between the Registrant and Geoffrey Gilmore (Filed With SEC on August 17, 2020)

Amended and Restated Employment Agreement, dated August 14, 2020, by and between the Registrant and Dennis Reilly (Filed With SEC on August 17, 2020)

Project Agreement, dated April 30, 2020, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on August 11, 2020)

Master Service Agreement, dated October 11. 2017, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on August 11, 2020)

First Amendment to Master Service Agreement, dated April 30, 2020, by and between the Registrant and inVentiv Commercial Services, LLC (Filed With SEC on August 11, 2020)

Manufacturing and Commercialization Agreement, dated April 30, 2020, by and between the Registrant and Corium, Inc (Filed With SEC on August 11, 2020)

Underwriting Agreement dated February 21, 2020 (Filed With SEC on February 21, 2020)

Description of Capital Stock (Filed With SEC on February 20, 2020)

Warrant Agreement between Agile Therapeutics, Inc. and Perceptive Credit Holdings III, LP, dated as of February 10, 2020 (Filed With SEC on February 12, 2020)

Credit Agreement and Guaranty among Agile Therapeutics, Inc., the guarantors from time to time party thereto, the lenders from time to time party thereto and Perceptive Credit... (Filed With SEC on February 12, 2020)

Common Stock Sales Agreement dated November 8, 2019 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 8, 2019)

Employment Agreement dated July 16, 2019 by and between the Registrant and Dennis P. Reilly (Filed With SEC on October 28, 2019)

Underwriting Agreement dated August 2, 2019 (Filed With SEC on August 2, 2019)

CLINICAL RESEARCH AGREEMENT (Filed With SEC on March 12, 2019)

Stock Purchase Agreement, dated as of March 4, 2019, by and among Agile Therapeutics, Inc. and the Purchasers Named Therein (Filed With SEC on March 4, 2019)

Common Stock Sales Agreement dated January 23, 2019 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 23, 2019)

Fourth Lease Amendment, dated April 22, 2016, by and between the Registrant and Bunn Farm Associates, LLC., and Fifth Lease Amendment dated December 1, 2016, by and between the... (Filed With SEC on March 12, 2018)

Form of Performance Unit Issuance Agreement (Filed With SEC on January 26, 2018)

5,333,334 Shares Agile Therapeutics, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on August 3, 2017)

AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 8, 2017)

AGILE THERAPEUTICS, INC. PERFORMANCE UNIT ISSUANCE AGREEMENT RECITALS (Filed With SEC on April 17, 2017)

AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 26, 2016)

AGILE THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on August 8, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2016)

5,511,812 Shares Agile Therapeutics, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on January 25, 2016)

THIRD LEASE AMENDMENT (Filed With SEC on November 9, 2015)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of AGILE THERAPEUTICS, INC. Dated as of February 24, 2015 (the Effective Date) (Filed With SEC on February 24, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on February 24, 2015)

AGILE THERAPEUTICS, INC. 101 POOR FARM ROAD PRINCETON, NEW JERSEY 08540 (Filed With SEC on February 24, 2015)

STOCK PURCHASE AGREEMENT By and Among AGILE THERAPEUTICS, INC. and THE PURCHASERS NAMED HEREIN Dated as of January 19, 2015 (Filed With SEC on January 23, 2015)

Shares Agile Therapeutics, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on May 9, 2014)

FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 9, 2014)

AGILE THERAPEUTICS, INC. 2014 INCENTIVE COMPENSATION PLAN ARTICLE ONE GENERAL PROVISIONS (Filed With SEC on May 9, 2014)

AGILE THERAPEUTICS, INC. CONVERTIBLE SUBORDINATED PROMISSORY NOTE (Filed With SEC on May 5, 2014)

AGILE THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 5, 2014)

DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 5, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on April 17, 2014)

FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 17, 2014)

AGILE THERAPEUTICS, INC. AMENDED AND RESTATED 1997 EQUITY INCENTIVE PLAN (Filed With SEC on March 17, 2014)

AGILE THERAPEUTICS, INC AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN (Filed With SEC on March 17, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2014)

DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 17, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 17, 2014)

CONSULTING AGREEMENT (Filed With SEC on March 17, 2014)

SUMMARY OF BASIC LEASE PROVISIONS (Filed With SEC on March 17, 2014)

Category

Industry

Companies

Contracts

AGILE THERAPEUTICS INC Contracts & Agreements